Ohad Atia

463 total citations
37 papers, 269 citations indexed

About

Ohad Atia is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Ohad Atia has authored 37 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 25 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Ohad Atia's work include Inflammatory Bowel Disease (30 papers), Microscopic Colitis (25 papers) and Eosinophilic Esophagitis (5 papers). Ohad Atia is often cited by papers focused on Inflammatory Bowel Disease (30 papers), Microscopic Colitis (25 papers) and Eosinophilic Esophagitis (5 papers). Ohad Atia collaborates with scholars based in Israel, United Kingdom and United States. Ohad Atia's co-authors include Dan Turner, Iris Dotan, Shira Greenfeld, Eran Matz, Revital Kariv, Gili Focht, Oren Ledder, Yiska Loewenberg Weisband, Daniel Nevo and Henit Yanai and has published in prestigious journals such as Alimentary Pharmacology & Therapeutics, Clinical Gastroenterology and Hepatology and Digestive Diseases and Sciences.

In The Last Decade

Ohad Atia

35 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ohad Atia Israel	10	221	166	83	40	36	37	269
Sally Lawrence Canada	9	260 1.2×	177 1.1×	108 1.3×	34 0.8×	77 2.1×	25	356
Pam Rogers United Kingdom	4	246 1.1×	177 1.1×	115 1.4×	29 0.7×	68 1.9×	6	328
Laura Armengol‐Debeir France	8	272 1.2×	171 1.0×	169 2.0×	33 0.8×	43 1.2×	15	355
Giulia D’Arcangelo Italy	10	217 1.0×	165 1.0×	108 1.3×	19 0.5×	32 0.9×	27	279
Farhat Ullah Khan Pakistan	3	328 1.5×	252 1.5×	177 2.1×	49 1.2×	58 1.6×	9	430
Chani Topf‐Olivestone Israel	6	218 1.0×	174 1.0×	54 0.7×	36 0.9×	81 2.3×	14	257
P. L. Fain United States	2	306 1.4×	196 1.2×	137 1.7×	34 0.8×	91 2.5×	4	368
Christine Spray United Kingdom	10	167 0.8×	158 1.0×	215 2.6×	31 0.8×	19 0.5×	30	388
Eleftheria Roma‐Giannikou Greece	13	134 0.6×	135 0.8×	163 2.0×	32 0.8×	70 1.9×	22	426
Sai Wei Chuah Singapore	8	151 0.7×	119 0.7×	62 0.7×	70 1.8×	76 2.1×	12	237

Countries citing papers authored by Ohad Atia

Since Specialization

Citations

This map shows the geographic impact of Ohad Atia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ohad Atia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ohad Atia more than expected).

Fields of papers citing papers by Ohad Atia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ohad Atia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ohad Atia. The network helps show where Ohad Atia may publish in the future.

Co-authorship network of co-authors of Ohad Atia

This figure shows the co-authorship network connecting the top 25 collaborators of Ohad Atia. A scholar is included among the top collaborators of Ohad Atia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ohad Atia. Ohad Atia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Atia, Ohad, Raffi Lev‐Tzion, Ronen Stein, et al.. (2025). Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study. The Lancet. Gastroenterology & hepatology. 10(3). 234–247. 2 indexed citations

Atia, Ohad, Amir Ben‐Tov, Mehdi Osooli, et al.. (2024). The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide Cohorts. Journal of Crohn s and Colitis. 18(8). 1241–1249. 5 indexed citations

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2024). Predictors of Complicated Disease Course in Adults and Children With Crohn’s Disease: A Nationwide Study from the epi-IIRN. Inflammatory Bowel Diseases. 30(12). 2370–2379. 3 indexed citations

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2024). Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN. Inflammatory Bowel Diseases. 31(3). 655–664. 3 indexed citations

Focht, Gili, Raffi Lev‐Tzion, Oren Ledder, et al.. (2024). Serological Markers as Predictors of Anti-TNF Response in Children with Crohn’s Disease. Digestive Diseases and Sciences. 70(1). 333–339.

Focht, Gili, Ohad Atia, Shira Greenfeld, et al.. (2023). OP12 Does early initiation of biologics change the natural history of IBD? a nationwide study from the epi-IIRN. Journal of Crohn s and Colitis. 17(Supplement_1). i17–i18. 2 indexed citations

Atia, Ohad, Gili Focht, Shira Greenfeld, et al.. (2023). Durability of the First Biologic in Patients with Crohn’s Disease: A Nationwide Study from the epi-IIRN. Journal of Crohn s and Colitis. 18(1). 38–46. 6 indexed citations

Atia, Ohad, Idan Goren, Shira Greenfeld, et al.. (2023). 5‐aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease—A nationwide cohort study. Alimentary Pharmacology & Therapeutics. 57(9). 1004–1013. 12 indexed citations

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2023). Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN. Inflammatory Bowel Diseases. 30(2). 213–221. 6 indexed citations

10.

Atia, Ohad, Raffi Lev‐Tzion, Richard I. Stein, et al.. (2023). P774 Maintenance treatment with vedolizumab in children with Inflammatory Bowel Disease: follow-up results from the prospective multicenter VEDOKIDS study. Journal of Crohn s and Colitis. 17(Supplement_1). i904–i905. 2 indexed citations

11.

Atia, Ohad, Reut Rotem, Simcha Yagel, et al.. (2023). A Scoring System Developed by a Machine Learning Algorithm to Better Predict Adnexal Torsion. Journal of Minimally Invasive Gynecology. 30(6). 486–493. 2 indexed citations

12.

Atia, Ohad, Lissy de Ridder, Polychronis Kemos, et al.. (2023). Validation of predictive models for disease outcomes in paediatric ulcerative colitis: A multicentre prospective inception cohort. Alimentary Pharmacology & Therapeutics. 58(2). 182–190. 4 indexed citations

13.

Atia, Ohad, Idan Goren, Yiska Loewenberg Weisband, et al.. (2023). P467 5-ASA is not superior to no-maintenance in patients with newly diagnosed Crohn’s disease - a nationwide cohort from the epi-IIRN. Journal of Crohn s and Colitis. 17(Supplement_1). i596–i596. 1 indexed citations

14.

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2023). DOP58 predictors of complicated disease course in CD in an administrative database: a nationwide study from the epi-IIRN. Journal of Crohn s and Colitis. 17(Supplement_1). i128–i130.

15.

Atia, Ohad, Eric I. Benchimol, Shira Greenfeld, et al.. (2022). Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study. Clinical Gastroenterology and Hepatology. 21(10). 2639–2648.e6. 12 indexed citations

16.

Atia, Ohad, Diane R. Mould, Ronen Stein, et al.. (2022). Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study. The Lancet. Gastroenterology & hepatology. 8(1). 31–42. 32 indexed citations

17.

Atia, Ohad, Esther Orlanski‐Meyer, Shira Greenfeld, et al.. (2021). Improved Outcomes of Paediatric and Adult Crohn’s Disease and Association With Emerging Use of Biologics–A Nationwide Study From the Epi-IIRN. Journal of Crohn s and Colitis. 16(5). 778–785. 19 indexed citations

18.

Atia, Ohad, Esther Orlanski‐Meyer, Shira Greenfeld, et al.. (2021). Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN. Journal of Crohn s and Colitis. 16(5). 796–803. 30 indexed citations

19.

Atia, Ohad, Reut Rotem, Orna Reichman, et al.. (2020). Number of prior vaginal deliveries and trial of labor after cesarean success. European Journal of Obstetrics & Gynecology and Reproductive Biology. 256. 189–193. 7 indexed citations

20.

Cohen‐Cymberknoh, Malena, Ohad Atia, Alex Gileles‐Hillel, Eitan Kerem, & Joel Reiter. (2019). Sleep disorders in patients with primary ciliary dyskinesia, cystic fibrosis with and without pancreatic insufficiency. Respiratory Medicine. 151. 96–101. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact